Yes, it will definitely be. The appointment of Arecur® in a case of leukoplakia is clinically justified: firstly, this is the necessary work of T-lymphocytes and macrophages against atypical cells in the epithelial layer, which is already subject to metaplasia, secondly, this is the direct effect of immune peptides on the focus of disease and prevention of its progression, this is the reduction of perifocal inflammation and normalization of microbiota. To achieve a clinically significant effect of Arecur® in case of leukoplakia, two 20-day courses of suppositories with a break of 10 days are recommended.